More Science in America: Providing More Ready-to-Administer Options

To help improve safety and efficiency – and, in some cases, to discourage drug diversion – many hospitals in the U.S. are transitioning to ready-to-administer (RTA) drug presentations. That’s why Fresenius Kabi is doing More in America to expand the ready-to-administer options available to clinicians and caregivers – by offering prefilled, standard strength, single-patient delivery platforms in syringes and IV bags.

Fresenius Kabi is committed to investing in science and technologies that support the safe delivery of medication. There’s good reason for this: Ready-to-administer medication systems are recommended by the Joint Commission,1 Institute for Safe Medication Practices (ISMP),2 American Society of Health-System Pharmacists (ASHP),3 and the Anesthesia Patient Safety Foundation (APSF).4

To streamline medication management from the pharmacy to the bedside and help eliminate steps where errors can occur, Fresenius Kabi offers Simplist™ prefilled syringes and freeflex® premixed IV bags for multiple medications in standardized strengths.

Simplist prefilled syringes simplify medication management at the point of care. These FDA-approved, manufacturer-prepared, cGMP compliant products offer from 24- to 36-month shelf life and require no assembly or point of care preparation. Each Simplist prefilled syringe is color-coded and differentiated, and prelabeled with the drug name, strength, expiration date, and barcode to assist with drug identification. One initiative of opioid stewardship is drug diversion. The availability of more precise and clinically relevant vial and prefilled syringe sizes may help address diversion by limiting the need for product waste and related documentation.[5] [Learn More]

The freeflex line of IV bags are innovatively designed to help clinicians deliver infusion care safely and efficiently. From the crystal-clear, non-PVC, non-DEHP bag and patented leak resistant technology to the easy-to-handle bag design and visually distinct labeling, every element of this innovative and flexible container system makes our line of premixed medications your simple choice for safe infusions. [Learn More]

Fresenius Kabi continues to bring more science to America through its portfolio of innovative ready-to-administer products – to offer more flexibility and choice to clinicians, enabling them to follow best practices in patient care. Please contact your sales representative to learn more about how Fresenius Kabi’s RTA offerings can support your clinical practice.

Fresenius Kabi is a global healthcare company that is doing More in America. We’re investing nearly a billion dollars in new pharmaceutical production facilities, new laboratories, new distribution centers and new ideas to help make America’s supply chain of care stronger and more resilient.

1 The Joint Commission. Prepublication requirements: revisions to the medication management standards regarding sample medications. Accessed May 4, 2020.

2 Institute for Safe Medication Practices. ISMP safe practice guidelines for adult IV push medications: a compilation of safe practices from the ISMP Adult IV Push Medication Safety Summit. Accessed July 11, 2020.

3 ASHP Guidelines: Minimum Standard for Pharmacies in Hospitals. (2013). American Journal of Health-System Pharmacy, 70(18), 1619-1630. doi:10.2146/sp130001.

4 Anesthesia Patient Safety Foundation. (2019). Recommendations of the Four Work Groups at the 2018 APSF Stoelting Conference on Medication Safety – Anesthesia Patient Safety Foundation. [Accessed 26 Jun. 2020].

5 Hertig, J., Jarrell, K., Arora, P., Nwabueze, J., Moureaud, C., Degnan, D. D., & Trujillo, T. (2020). A Continuous Observation Workflow Time Study to Assess Intravenous Push Waste. Hospital Pharmacy.